| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |